Development and Validation of a Single-Well Cell-Based Assay for the Detection of Endogenous Phosphoproteins

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Assay and drug development technologies

• Publication date

  2013-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1089/adt.2012.471PMID 23062078
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of IGF-1/PI3K/Akt signalling by the phosphoinositide phosphatase pharbin.

  2011cited by this paper
• Lessons on transcriptional control from the serum response network.

  2011cited by this paper
• Solution ELISA as a platform of choice for development of robust, drug tolerant immunogenicity assays in support of drug development.

  2011cited by this paper
• Quantitative Phosphoproteomics Reveals Widespread Full Phosphorylation Site Occupancy During Mitosis

  2010cited by this paper
• Development of cell-based assays for cytokine receptor signaling, using an AlphaScreen SureFire assay format.

  2010cited by this paper
• Quantitative phosphoproteomics

  2010cited by this paper
• Integrins and signal transduction.

  2010cited by this paper
• Regulation of PTEN/Akt and MAP kinase signaling pathways by the ubiquitin ligase activators Ndfip1 and Ndfip2

  2010cited by this paper
• The MARCKS Protein Plays a Critical Role in Phosphatidylinositol 4,5-Bisphosphate Metabolism and Directed Cell Movement in Vascular Endothelial Cells*

  2010cited by this paper
• An emerging role for kinase screening in GPCR drug discovery.

  2010cited by this paper
• Kinase mutations in human disease: interpreting genotype–phenotype relationships

  2010cited by this paper
• Protein kinase B (PKB/Akt), a key mediator of the PI3K signaling pathway.

  2010cited by this paper
• Toward an in situ phospho‐protein atlas: phospho‐ and site‐specific antibody‐based spatio‐temporally systematized detection of phosphorylated proteins in vivo

  2009cited by this paper
• Immunohistochemical assessment of protein phosphorylation state: the dream and the reality

  2008cited by this paper
• High-content analysis of kinase activity in cells.

  2008cited by this paper
• hSef potentiates EGF-mediated MAPK signaling through affecting EGFR trafficking and degradation.

  2008cited by this paper
• Pharmacological Profiling of Chemokine Receptor–Directed Compounds Using High-Content Screening

  2008cited by this paper
• Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases.

  2007cited by this paper
• Cell signaling branches out

  2006cited by this paper
• p38 kinase regulates epidermal growth factor receptor downregulation and cellular migration

  2006cited by this paper
• Enzyme immunoassay (EIA)/enzyme-linked immunosorbent assay (ELISA).

  2005cited by this paper
• Phosphorylation state-specific antibodies: applications in investigative and diagnostic pathology.

  2003cited by this paper
• Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase.

  1994cited by this paper
• A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).

  1994cited by this paper

• No citing papers are available for this paper.